Immediate Impact
25 standout
Citing Papers
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Works of M. Pretel being referenced
Adverse Skin Effects of Imatinib, a Tyrosine Kinase Inhibitor
2014
Efectos adversos cutáneos del imatinib (inhibidor de la tirosín cinasa)
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| M. Pretel | 111 | 81 | 136 | 26 | 363 | |
| Elisa Moliterni | 75 | 70 | 123 | 30 | 327 | |
| R.P.R. Dawber | 196 | 84 | 117 | 27 | 410 | |
| Ziba Rahbar | 125 | 60 | 128 | 19 | 362 | |
| Deniz Yücelten | 129 | 47 | 61 | 26 | 369 | |
| Necmettin Kırtak | 124 | 110 | 76 | 23 | 407 | |
| Nadira Ruzehaji | 55 | 53 | 131 | 14 | 403 | |
| J.M. Naeyaert | 121 | 72 | 88 | 18 | 327 | |
| A. Tamura | 61 | 68 | 119 | 24 | 304 | |
| Hatice Şanlı | 155 | 37 | 94 | 33 | 322 | |
| P.D.C. Kinmont | 89 | 70 | 90 | 23 | 334 |
All Works
Login with ORCID to disown or claim papers
Loading papers...